Literature DB >> 27817845

Antidepressant Actions of Ketamine Versus Hydroxynorketamine.

Graham L Collingridge1, Yeseul Lee2, Zuner A Bortolotto2, Heather Kang2, David Lodge2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27817845     DOI： 10.1016/j.biopsych.2016.06.029

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  13 in total

1.  Effects of a ketamine metabolite on synaptic NMDAR function.

Authors:  Kanzo Suzuki; Elena Nosyreva; Kevin W Hunt; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2017-06-21       Impact factor: 49.962

2.  Alternatives to ketamine in depression: state-of-the-art and future perspectives.

Authors:  Luke A Jelen; Sinead King; James M Stone
Journal:  Ther Adv Psychopharmacol       Date:  2017-12-18

Review 3.  Rodent ketamine depression-related research: Finding patterns in a literature of variability.

Authors:  Andrew J Polis; Paul J Fitzgerald; Pho J Hale; Brendon O Watson
Journal:  Behav Brain Res       Date:  2019-08-13       Impact factor: 3.332

4.  Family of Structurally Related Bioconjugates Yields Antibodies with Differential Selectivity against Ketamine and 6-Hydroxynorketamine.

Authors:  Zhen Zheng; Jillian L Kyzer; Adam Worob; Cody J Wenthur
Journal:  ACS Chem Neurosci       Date:  2021-10-15       Impact factor: 5.780

Review 5.  Dendritic Spine Elimination: Molecular Mechanisms and Implications.

Authors:  Ivar S Stein; Karen Zito
Journal:  Neuroscientist       Date:  2018-05-02       Impact factor: 7.519

Review 6.  Backing into the future: pharmacological approaches to the management of resistant depression.

Authors:  P J Cowen
Journal:  Psychol Med       Date:  2017-08-25       Impact factor: 7.723

7.  BDNF at the synapse: why location matters.

Authors:  M Song; K Martinowich; F S Lee
Journal:  Mol Psychiatry       Date:  2017-07-25       Impact factor: 15.992

8.  Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.

Authors:  Kai Zhang; Yuko Fujita; Kenji Hashimoto
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

9.  Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients.

Authors:  Chadi G Abdallah; Arpan Dutta; Christopher L Averill; Shane McKie; Teddy J Akiki; Lynnette A Averill; J F William Deakin
Journal:  Chronic Stress (Thousand Oaks)       Date:  2018-09-21

10.  Intravascular Ketamine Increases Theta-Burst but Not High Frequency Tetanus Induced LTP at CA3-CA1 Synapses Within Three Hours and Devoid of an Increase in Spine Density.

Authors:  Allie J Widman; Amy E Stewart; Elise M Erb; Elizabeth Gardner; Lori L McMahon
Journal:  Front Synaptic Neurosci       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.